These data showed that both CMs were able to activate the PI3K-AKT pathway, which is involved in cell survival mechanisms, corroborating the predicted PPI network and previous results about the effect of NCM and HCM on endothelial cell survival and proliferation. The gene discussed is AKT1; the disease is neurocutaneous melanocytosis.